The Covid Consortium

The COVID Consortium brings the critical and necessary resources of multiple CLIA certified, CAP and COLA accredited medium and high complexity laboratories, clinicians and technology together to allow the delivery of a consistent COVID-19 test with equally consistent result delivery.

favicon

Who We Are

In Mid March, as the COVID-19 crisis continued in the U.S., one thing became clear to the medical staff at CopernicusMD; either States didn’t desire mass testing for COVID-19 infection or, they simply couldn’t organize it. 

It was puzzling to think that with the resources of the Federal and State governments on both an academic and financial level that broad-based testing in every state could not be mobilized.  So the Medical team at CopernicusMD got to work.

Mission

The mission of the COVID Consortium has two critical priority points.

We recognize the need for reliable, clinically valid testing at scale.

We recognize the need for broad based COVID-19 testing at the employer level to support the re-opening of the American economy.

Latest in the News

Get the latest news for your business from the experts.

  • Cases in the U.S.
    on April 9, 2021 at 7:49 pm

    CDC COVID Data Tracker - Cases and Deaths by State

  • Strategies for Optimizing Supply of N95 Respirators
    on April 9, 2021 at 4:00 am

    Learn how to optimize N95 respirators during COVID-19.

  • Guidance for Reporting SARS-CoV-2 Sequencing Results
    on April 9, 2021 at 4:00 am

    It is critically important for the nation's COVID-19 pandemic response to understand the genetic diversity, spread, and evolution of SARS-CoV-2, including variant viruses. This guidance for reporting SARS-CoV-2 sequencing will improve that understanding.

  • Public Service Announcements (PSAs)
    on April 9, 2021 at 4:00 am

    List of public service announcements related to coronavirus.

  • Understanding Viral Vector COVID-19 Vaccines
    on April 9, 2021 at 4:00 am

    Viral vector vaccines are a type of vaccine likely to be approved for use for COVID-19 that work differently from the initially approved mRNA vaccines.

  • SPHERES
    on April 9, 2021 at 4:00 am

    With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.